- Home
- EXEL vs WLK Comparison
EXEL vs WLK Comparison
Compare EXEL & WLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- WLK
- Stock Information
- Founded
- EXEL 1994
- WLK 1986
- Country
- EXEL United States
- WLK United States
- Employees
- EXEL N/A
- WLK N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- WLK Major Chemicals
- Sector
- EXEL Health Care
- WLK Industrials
- Exchange
- EXEL Nasdaq
- WLK Nasdaq
- Market Cap
- EXEL 10.4B
- WLK 10.1B
- IPO Year
- EXEL 2000
- WLK 2004
- Fundamental
- Price
- EXEL $38.12
- WLK $68.45
- Analyst Decision
- EXEL Buy
- WLK Buy
- Analyst Count
- EXEL 23
- WLK 16
- Target Price
- EXEL $44.10
- WLK $93.00
- AVG Volume (30 Days)
- EXEL 3.0M
- WLK 1.3M
- Earning Date
- EXEL 11-04-2025
- WLK 10-30-2025
- Dividend Yield
- EXEL N/A
- WLK 3.10%
- EPS Growth
- EXEL 81.76
- WLK N/A
- EPS
- EXEL 2.08
- WLK N/A
- Revenue
- EXEL $2,230,005,000.00
- WLK $11,480,000,000.00
- Revenue This Year
- EXEL $9.14
- WLK N/A
- Revenue Next Year
- EXEL $12.51
- WLK $3.14
- P/E Ratio
- EXEL $18.32
- WLK N/A
- Revenue Growth
- EXEL 10.73
- WLK N/A
- 52 Week Low
- EXEL $31.90
- WLK $65.77
- 52 Week High
- EXEL $49.62
- WLK $139.59
- Technical
- Relative Strength Index (RSI)
- EXEL 46.88
- WLK 31.97
- Support Level
- EXEL $33.76
- WLK $65.77
- Resistance Level
- EXEL $40.63
- WLK $80.28
- Average True Range (ATR)
- EXEL 1.31
- WLK 2.55
- MACD
- EXEL 0.07
- WLK -0.83
- Stochastic Oscillator
- EXEL 63.54
- WLK 18.47
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About WLK Westlake Corporation
Westlake Corp is a manufacturer and supplier of chemicals, polymers, and building products. Its Performance and Essential Materials segment offers a wide range of essential building blocks for making products utilized in everyday living, including olefins, vinyl chemicals, polyethylene, and epoxies. Its Housing and Infrastructure Products segment produces key finished goods for building products, pipe and fittings, and global compounds businesses.